AKT2 and osteosarcoma: In this study, we demonstrated that RhoA activation acts as the downstream of Wnt5a/PI3K/Akt signaling, and is specifically regulated by PI3Kα, Akt1 and Akt2 isoforms in osteosarcoma cells.